Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
about
Hepatitis C Virus, Insulin Resistance, and SteatosisHepatitis C and insulin action: An intimate relationshipReview article: HCV genotype 3 – the new treatment challengeAssociation between vitamin D and hepatitis C virus infection: a meta-analysisInsulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients.Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.Comparison of hepatitis C virus treatment between incarcerated and community patientsSustained Virologic Response to a Dual Peginterferon alfa-2a and Ribavirin in Treating Chronic hepatitis C Infection: A Retrospective Cohort Study.Motor vehicle accidents: how should cirrhotic patients be managed?Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.Nutrition therapy for liver diseases based on the status of nutritional intake.Dipeptidyl peptidase-4: a key player in chronic liver disease.Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.Individualization of chronic hepatitis C treatment according to the host characteristics.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review.Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C.Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes.n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative StudyCharacterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients.Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.Does telaprevir possess a direct antidiabetic effect?Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro.Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.Polypharmacy and comorbidity are associated with a lower early virologic response in hepatitis C patients treated with first generation protease inhibitor triple therapy: a preliminary analysis.Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy.
P2860
Q26751755-981C1BB7-7872-49B5-8FB7-34D279FAB045Q26775000-404B57EE-2A8E-46F1-9C0D-7316C8657118Q26864571-8AA26F4D-55A0-4982-947B-42022462E1E4Q26866361-9317167D-2AD1-4644-AB9A-150FE950ACFCQ34467208-0B8C1E7D-896C-468E-9DFF-885BBB714634Q34825751-AB4CA822-93D3-41ED-8990-3029810293B0Q35188071-A175E71C-A61E-47B5-A749-BC2E6DBD273CQ35591160-A867EE8F-272F-46E5-8803-046867F61214Q35915031-D8F9380C-A379-444F-A3BD-B5480F89002AQ36009336-409BC4D3-16BE-4E6D-B255-DAEFD3713ACBQ36015996-80EB0D96-0FF7-4544-B5D3-7665FDCCF08BQ36026554-CCA506F3-027F-4288-AA97-3638053D55B7Q36379566-8DDBF45F-2B2C-4629-848E-E31067D03162Q36391682-014B0EA0-4B40-4ADC-A94E-A6177377A6BAQ36417913-1085EA90-2836-4DF6-AA4D-BFC271EB0A16Q36783164-08F59462-3804-42A3-A6CB-B95CA5674954Q37113118-72D3EC70-E699-4A60-B941-8D21245320EEQ37285273-C60ED1D6-FCAF-4039-B0DB-12324C47C5E3Q37654502-F441DE81-4ACA-4157-96DE-61804B54905FQ37685491-74D63266-C6D9-45D3-88C3-2427D052748BQ38249236-A5BE44E3-5A10-4190-9023-AF6AB931FE65Q38351750-43179101-CCA6-4A5A-A945-D7352B73A895Q38853078-EC9BCAAB-06B0-4106-A4D4-84B2B9B8A2E1Q39146830-774614CF-B447-498F-B141-45C2004927BFQ39954657-924999DE-5A14-4304-8900-74D80A1ADD48Q40051943-378FA527-83E4-4D9D-B5BE-26655B552835Q40451958-5E980D86-8C40-4902-B829-1FBE93B578A1Q40689561-9781A22A-11AB-4506-B2DC-A234DD6C6A14Q41717451-C98C2A94-22ED-4E73-B737-086025ADB5C4Q42239659-29BC26A0-F112-4F4B-BCA8-79623F10B93FQ42241367-865A8838-6EE0-4255-906D-FFB721C4E350Q42242609-F5D7813A-F44D-4805-BD11-2CFC23579375Q42245782-736E9C47-7B4B-496B-B656-834276C7DF0FQ42249687-EE77F722-22EE-4D85-BC07-2F6F097E23BCQ42257920-C3A2ABDA-17A9-4BE9-A426-345F2EF0F4D2Q42259157-8153C563-910C-428E-B38A-EF0E3C655B5DQ42278251-9BA98870-5661-4BCB-A74F-32D806AF89EFQ42919523-4B54D9EA-27A9-4F61-97BC-4F78C2DC122FQ42980606-72EF58AE-AEFB-4B4E-9ACA-678ECC6D81F3Q42983726-F8E59CA0-7A33-4C56-A8F7-C5418912A363
P2860
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@en
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@nl
type
label
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@en
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@nl
prefLabel
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@en
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@nl
P2093
P2860
P1476
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
@en
P2093
J A Del Campo
M A Khattab
M Romero-Gomez
R Aparcero
T Kawaguchi
P2860
P304
P356
10.1111/J.1365-2036.2011.04716.X
P407
P577
2011-05-29T00:00:00Z